Skip to main content
Premium Trial:

Request an Annual Quote

Microfluidic Systems to Use ABI Assays in Bioagent Detector

NEW YORK (GenomeWeb News) – Microfluidic Systems yesterday said that it will use Applied Biosystems’ TaqMan assays in its Bioagent Autonomous Networked Detector for airborne pathogens.
 
Microfluidic Systems said that ABI will manufacture the assays, which can be used for detecting harmful pathogens. It noted that ABI’s TaqMan assays have provided more than 5.2 million anthrax screening tests through ongoing mail-screening applications.
 
The US Department of Homeland Security’s Science and Technology Directorate has been funding development of BAND for the past three years. The goal of the program is to monitor air quality in cities or large regions for biosecurity threats, such as anthrax, plague, and smallpox.
 
Under a separate agreement also announced today, the Hamilton Sundstrand unit of United Technologies will provide design for manufacturing, pilot production, high-volume manufacturing, and product support of the BAND system.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.